Details of the Metabolic Reaction (MR)

General Information of This Metabolic Reaction (MR) (ID: MR003721)
Formula Reactant Sacubitril Product LCZ-696 Metabolite M2
Reactant Info Product Info
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Produce The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR003714 LCZ-696 Sacubitril Hydrolysis - Ester hydrolysis LCZ-696 [1]
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR003715 Sacubitril LBQ657 Hydrolysis - Ester hydrolysis LCZ-696 [2], [3], [1]
MR003723 Sacubitril LCZ-696 Metabolite M3 Unclear LCZ-696 [1]
Other MR(s) Related to The Product of This MR
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR003722 LCZ-696 Metabolite M2 LCZ-696 Metabolite M9 Unclear LCZ-696 [1]
References
1 Disposition and metabolism of [(14)C] Sacubitril/Valsartan (formerly LCZ696) an angiotensin receptor neprilysin inhibitor, in healthy subjects
2 Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi)
3 Dicarboxylic acid dipeptide neutral endopeptidase inhibitors

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.